BIORA THERAPEUTICS, INC. (BIOR) Deferred Tax Assets, Valuation Allowance USD 2019 - 2023

Historical data

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Biora Therapeutics, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from 2019 to 2023.
  • Biora Therapeutics, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2023 was $149 M, a 5.31% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $149 M +$7.49 M +5.31% Dec 31, 2023 10-K 2024-04-01
Q4 2022 $141 M +$11.8 M +9.1% Dec 31, 2022 10-K 2024-04-01
Q4 2021 $129 M +$29.5 M +29.6% Dec 31, 2021 10-K 2023-03-30
Q4 2020 $99.9 M +$29.8 M +42.6% Dec 31, 2020 10-K 2022-03-28
Q4 2019 $70 M Dec 31, 2019 10-K 2021-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.